Peter Kleim und Jörg-Peter - Info zur Person

(1 - 15 von 15

)

Pharmacokinetic Interactions and Safety Evaluations of ...Medicines for Malaria Venture

www.mmv.org

— Ann K Miller, Emma Harrell, Li Ye, Sharon Baptiste-Brown, Jörg-Peter Kleim, Colin Ohrt, Stephan Duparc, Jörg J Möhrle, Alison Webster, ...

LinkedIn: Joerg-Peter Kleim | LinkedIn

View Joerg-Peter Kleim's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Joerg-Peter Kleim ...

Second-generation non-nucleosidic reverse transcriptase ...The Lancet

www.thelancet.com

Helga Rübsamen-Waigmann, Edward Huguenel, Arno Paessens, Jörg-Peter Kleim, Mark A Wainberg, Anita Shah to –1·38 log10) (table). In one of five patients who ...

Trends in Drug Research II - Google Books

books.google.cz

HBY a second-generation nonnucleoside inhibitor of the HIV-1 reverse transcriptase Jörg-Peter Kleim Central Pharma Research / HIV, Hoechst AG, ...

Absence of human immunodeficiency virus (HIV) proviral ...John Wiley

onlinelibrary.wiley.com

Hoechst AG, Frankfurt, Germany. Jörg-Peter Kleim, PhD, Junior Scientist, Institute for Medical Microbiology and Immunology.

Tafenoquine for radical cure of Plasmodium vivax malaria: a...

proceedings.science

... Lon Chanthap ; Daniel Yilma ; Rezika Mohammed ; Srivicha Krudsood ; Dhelio Pereira ; Fe Espino ; Harald Noedl ; Brian Angus ; Joerg-Peter Kleim ; Stephan ...

DE A1 - Neuer Angiotensin Rezeptor, Herstellung und Verwendung...

patents.google.com

... German: English; Inventor: Holger Heitsch: Joerg-Peter Kleim: Guenther Ries: Gertrud Sibenhorn; Current Assignee ... Sanofi Aventis Deutschland GmbH ...

EP A2 - Neuer angiotensin rezeptor, herstellung und verwendung...

patents.google.com

... Inventor: Holger Heitsch: Jörg-Peter Kleim: Günther Riess: Gertrud Sibenhorn; Current Assignee ... Application filed by Sanofi Aventis Deutschland GmbH.

Jörg-Peter Kleim's scientific contributionsResearchGate

www.researchgate.net

Jörg-Peter Kleim's 4 research works with 468 citations and reads, including: Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous...

www.ajtmh.org

Emma J. Harrell, Vicki Rousell, Khadeeja Mohamed, Ammar Qureshi, Nushara Yubon, Jörg-Peter Kleim, and Justin A. Green are employees of, and hold stock ...

Antiviral Activity of the Human Immunodeficiency Virus Type Oxford University Press

academic.oup.com

... Type 1—Specific Nonnucleoside Reverse Transcriptase Inhibitor HBY 097 Alone and in Combination with Zidovudine in a Phase II Study. Jörg-Peter Kleim,.

Antiviral activity and safety of aplaviroc with lamivudine/ ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

Judith Currier , Adriano Lazzarin, Louis Sloan, Nathan Clumeck, Jihad Slims, Deb McCarty, Helen Steel, Jörg-Peter Kleim, Tab Bonny, Judith Millard; ...

Concomitant combination therapy for HIV infection ...PNAS

www.pnas.org

Jan Balzarini, Heidi Pelemans, Anna Karlsson, +1 , Erik De Clercq, and Jörg-Peter Kleim -1Authors Info & Affiliations. November 12,

Many malaria prophylaxis options, but none perfectACPinternist.org

acpinternist.org

... at both safety and efficacy, [it] might actually be satisfactory,” said Jörg-Peter Kleim, PhD, director of clinical development at GlaxoSmithKline.

Altmetric – Mutations in the non-nucleoside binding-pocket interfere...

www.altmetric.com

Kristel Van Laethem, Myriam Witvrouw, Christophe Pannecouque, Barbara Van Remoortel, Jean-Claude Schmit, Robert Esnouf, Jörg-Peter Kleim, Jan Balzarini, ...

Alle Infos zum Namen "Peter Kleim"

Verwandte Suchanfragen zu Peter Kleim

Donald Trump
Günther Riess
Holger Heitsch

Ulrich Oppold
Jörg Peter
Mario Kliem

Pierre Bouchez
Boris Heitmann
Christian Rymell

Person "Kleim" (2)
Vorname "Peter" (123603)
Name "Kleim" (128)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Peter Kleim und Jörg-Peter Person-Info